Daniel G. Weiss - 25 May 2022 Form 4 Insider Report for TPI COMPOSITES, INC (TPIC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 May 2022, 16:08:35 UTC
Prior SEC filing
03 May 2022
Next SEC filing
12 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Steven G. Fishbach, Attorney-in-Fact

Key filing fact

Daniel G. Weiss filed Form 4 for TPI COMPOSITES, INC (TPIC) on 27 May 2022.

Key facts

  • This page summarizes Daniel G. Weiss's Form 4 filing for TPI COMPOSITES, INC (TPIC).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 May 2022, 16:08.

Change

  • Previous filing in this sequence was filed on 03 May 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TPIC transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+2,335
Change %
+13%
Price
$0.000000
Shares after
20,804
Date
25 May 2022
Ownership
Direct
Footnotes
F1
TPIC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
102,571
Date
25 May 2022
Ownership
See Footnote
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TPIC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-2,335
Change %
-100%
Price
$0.000000*
Shares after
0
Date
25 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,335
Exercise price
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Reporting Person is contractually obligated to turn over any proceeds from the sale of these shares to Angeleno Investors II, L.P ("AI II LP") and/or certain entities affiliated with AI II LP. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any.

Footnote F2

These securities are held directly by Angeleno Global Equities, L.P. and AI II LP. Angeleno Equity Group I, LLC is the general partner of Angeleno Global Equities, L.P. Angeleno GroupManagement II, LLC is the General Partner of AI II LP and Angeleno Group, LLC is the Managing Member of Angeleno Group Management II, LLC. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended, except to the extent of its pecuniary interest therein, if any.

Footnote F3

The restricted stock units ("RSUs ") shall vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the next annual meeting of stockholders of the Issuer, subject to the Reporting Person's continued service as a director pursuant to the Issuer's Non-Employee Director Compensation Policy.

Footnote F4

Each RSU represents a contingent right to receive one share of Common Stock. All unvested RSUs will automatically expire upon the Reporting Person's termination of service from the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .